258 related articles for article (PubMed ID: 10526698)
21. The role of beta-adrenergic blocking agents in preventing sudden cardiac death.
Pitt B
Circulation; 1992 Jan; 85(1 Suppl):I107-11. PubMed ID: 1345815
[TBL] [Abstract][Full Text] [Related]
22. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
23. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
[TBL] [Abstract][Full Text] [Related]
24. beta-Blockers and myocardial infarction.
Moser M; Gorlin R
Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165
[No Abstract] [Full Text] [Related]
25. Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?
Hjalmarson A
Basic Res Cardiol; 2000; 95 Suppl 1():I41-5. PubMed ID: 11192352
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
27. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
[TBL] [Abstract][Full Text] [Related]
28. Possible role of beta-blockers in the prevention of sudden cardiac death (SCD) in patients with coronary heart disease (CHD).
Lamaida N; Capuano V; Di Mauro G; Aucello G; Scotto Di Quacquaro G
Panminerva Med; 1994 Jun; 36(2):71-5. PubMed ID: 7831062
[TBL] [Abstract][Full Text] [Related]
29. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
Haas SJ; Vos T; Gilbert RE; Krum H
Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
[TBL] [Abstract][Full Text] [Related]
30. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.
Heller DA; Ahern FM; Kozak M
Am Heart J; 2000 Oct; 140(4):663-71. PubMed ID: 11011343
[TBL] [Abstract][Full Text] [Related]
31. The cellular and physiologic effects of beta blockers in heart failure.
Sabbah HN
Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
[TBL] [Abstract][Full Text] [Related]
32. Do beta-blockers prolong survival in chronic heart failure? A review of the experimental and clinical evidence.
Packer M
Eur Heart J; 1998 Feb; 19 Suppl B():B40-6. PubMed ID: 9519351
[TBL] [Abstract][Full Text] [Related]
33. Effects of beta-blockers on glucose and lipid metabolism.
Fonseca VA
Curr Med Res Opin; 2010 Mar; 26(3):615-29. PubMed ID: 20067434
[TBL] [Abstract][Full Text] [Related]
34. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
[TBL] [Abstract][Full Text] [Related]
35. Beta-blockers in hypertensive and coronary heart disease.
Goldstein S
Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
[TBL] [Abstract][Full Text] [Related]
36. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
[TBL] [Abstract][Full Text] [Related]
37. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
Wikstrand J
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
[TBL] [Abstract][Full Text] [Related]
38. [Beta blockers in arrhythmias].
Fuhrer J
Praxis (Bern 1994); 1995 Mar; 84(11):304-12. PubMed ID: 7724946
[TBL] [Abstract][Full Text] [Related]
39. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
Mösslacher H
Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
[TBL] [Abstract][Full Text] [Related]
40. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
